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Post-embedding immunogold electron microscopy shows several binding sites for cholera toxin in mouse intestinal epithe- 
lial cells, particularly in the heterochromatin of the nucleus as well as in the plasma membrane. Anti-ganglioside GM1 
antibodies also bound to the nucleus, but did not interfere with the binding of toxin. *ZSI-labelled toxin bound specifically 
to a nuclear preparation from rabbit intestinal cells. 
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1. INTRODUCTION 
Cholera toxin (MI 84000, for general review see 
[l]) is composed of one A subunit and five B 
subunits. The B subunits bind to the outer mem- 
brane of cells and, by a mechanism not yet 
understood, this leads to the entry into the cell of 
the Al polypeptide of the A subunit which ac- 
tivates adenylate cyclase by catalysing the ADP- 
ribosylation of the regulatory G, protein. The 
binding of the B subunits is almost exclusively to 
ganglioside GM1 in the outer membrane. Binding 
is tight (Kd = 10e9 M) and specific: cholera toxin 
has often been used as a marker for ganglioside 
GMl. 
Previous studies in which the ganglioside GM1 
was localized immunocytochemically have used 
toxin incubated with cells, followed by labelling 
with peroxidase-conjugated antitoxin [2] or with 
immunogold [3,4] before embedding. They have 
shown ganglioside GM1 only on the external 
membrane. 
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In the experiments described in this paper we 
used the post-embedding immunogold method [5] 
to investigate binding sites for cholera toxin in 
epithelial cells of mouse small intestine. Labelling 
under these conditions shows binding sites (both 
intra- and extracellular) that are available to the 
toxin after the tissue had been fixed and sectioned: 
this does not imply that such sites would be accessi- 
ble to the toxin in intact cells or in vivo. This 
technique has been used previously, for example, 
in investigating the intracellular localization of 
regulatory polypeptides [6]. We found binding 
sites for the toxin in the microvilli, in the plasma 
membrane, and in the heterochromatin of the 
nucleus. 
2. MATERIALS AND METHODS 
2.1. Preparation of tissue for electron microscopy 
Small pieces of freshly excised mouse small intestine were fix- 
ed in 1% paraformaldehyde, 0.05% glutaraldehyde, 0.15 M 
NaCl, 50 mM phosphate buffer, pH 7.4, for 2 h at 4”C, washed 
in this buffer overnight at 4”C, dehydrated through ethanol; 
and embedded in hydrophilic resin (3 parts LR gold resin, Lon- 
don Resin Co.; 2 parts glycol methacrylate low acid, and 0.01% 
benzoin ethyl ester, Polysciences). The resin was polymerized 
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by ultra-violet radiation (360 nm) for 24 h at room expected protein profile [lo]. The plasma membrane-marker 
temperature. enzyme sucrase was assayed by the method of Dahlqvist [l 11. 
2.2. Immunokabelling 2.4. Measurement of toxin binding 
Ultrathin sections mounted on collodion-coated nickel grids 
were incubated with 0.5 M NH&I, in a buffer containing 
0.15 M NaCl, 50 mM phosphate, pH 7.0, for 1 h at room 
temperature to block free aldehyde groups; washed with several 
changes of buffer, and incubated first for 30 min in 1 mg/ml 
ovalbumin, and then for 30 min in 850 ng/ml cholera toxin 
(supplied by Sigma, and used at a concentration chosen ex- 
perimentally to give specific labelling and a very low 
background). After several washes in buffer, they were in- 
cubated for 1 h in rabbit anti-(cholera toxin) serum [6] (diluted 
250 times in the buffer), washed again and finally incubated for 
30 min with goat anti-(rabbit IgG) labelled with 15 nm gold 
(Janssen Pharmaceuticals) diluted fifty times. All incubations 
were at 37°C. After further washings in buffer and then in 
water, the grids were counterstained in 2% uranyl acetate and 
lead citrate, and examined with a Jeol lOOCX2 electron 
microscope. 
Cholera toxin was iodinated using chloramine-T [12], and 
used at about 70 GBq/pmol. Its binding to the nuclear prepara- 
tion was measured essentially as described by Griffiths et al. 
[13] except hat the buffer was 55 mM Tris-HCl, 80 mM NaCl, 
10 mM mannose, 3 mM KzHPO~, 1 mM MgClz, 1 mM CaCl2, 
pH 7.4.250 /tl of the nuclear preparation (400 /g/ml) were used 
for each triplicate determination. Controls using a forty-fold 
excess of unlabelled toxin were subtracted from experimental 
data. All duplicates showed less than 10% variation. 
3. RESULTS 
3. I. Post-embedding immunogold electron 
microscopy 
Some results from the experiments designed to 
2.3. Preparation of a nuclear fraction 
Nuclei were prepared from rabbit intestinal epithelial cells 
(prepared from gut scrapings) by the method of Bloebel and 
Potter [S]. A preparation of nuclear envelope with associated 
heterochromatin was prepared from this by the method of Har- 
ris and Milne [9]. It was analysed by polyacrylamide gel elec- 
trophoresis in the presence of SDS, and shown to have the 
show binding sites for cholera toxin are shown in 
fig.1. There are two major sites, together with 
some low levels of binding elsewhere in the cell, 
e.g. to vesicular structures (perhaps lysosomes and 
coated vesicles) in the cytoplasm. As would have 
been predicted from earlier work, there was exten- 
sive binding of whole toxin or of isolated subunit 
a 
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B to the plasma membrane and microvilli (as 
shown in fig.la). More surprisingly, under the 
same experimental conditions, there was a heavy 
distribution of colloidal gold on the hetero- 
chromatin of the nuclei (fig.lb). These ex- 
periments were done with many different samples, 
and in all cases the major binding was to the 
plasma membrane and to the nucleus. 
Controls were carried out to show that the 
observed nuclear binding was specific for toxin, 
and not, for example, to non-specific binding of 
the antibodies used in the immunogold labelling. 
Fig. 1. Electron micrographs of sectioned mouse intestinal tissue treated post-embedding with cholera toxin and immunogold. (a) 
Microvilli treated with 850 ng/ml whole toxin; (b) nuclei from the basal end of adjacent epithelial cells treated with 1 pg/ml subunit 
B. Bars are I pm long. 
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No gold was observed to bind to the nucleus or to 
the microvilli when (i) the rabbit antitoxin had 
been preadsorbed with toxin; (ii) cholera toxin was 
omitted; (iii) rabbit antitoxin was omitted; and (iv) 
the incubation was done with gold-labelled second 
antibody alone without toxin or second antibody. 
Essentially identical binding was observed 
following similar experiments with rat intestinal 
cells. 
3.2. Are the binding sites ganglioside Gnir ? 
Several experiments were performed in order to 
find out whether the binding sites in the nuclei 
were ganglioside GMl. For example, toxin that 
had been preincubated with a 2 x 105-fold molar 
excess of ganglioside failed to bind, presumably 
because the binding site on the toxin was no longer 
available (although conceivably because of 
transmitted conformational change to a different 
binding site). Binding experiments done not with 
toxin but with a polyclonal anti-GM1 antibody 
preparation (kindly given to us by Dr N. Gregson 
of Guy’s Hospital, London) gave very similar 
results to those found with toxin, suggesting a 
similar distribution of ganglioside and toxin- 
binding sites. However, preincubation of the post- 
embedded tissue with this antibody did not inhibit 
subsequent binding of toxin, nor did preincubation 
with toxin inhibit binding of antibody. 
3.3. Biochemical measurement of binding 
In order to verify that there are toxin-binding 
sites present in the nucleus, direct binding ex- 
periments were performed using ‘251-labelled toxin 
and a preparation of nuclear envelope from rabbit 
intestine. 
Fig.2 shows a measurement of the binding of 
12’I-labelled toxin to this preparation: the results 
are corrected for non-specific binding. Analysis of 
these data shows that they are compatible with a 
model in which there are about 4 x 1012 high- 
affinity binding sites (& about 2 nM) per mg pro- 
tein, and about 6 x 1013 per mg of lower affinity 
(& about 70 nM). 
Preliminary binding experiments using nuclear 
proteins adsorbed to microtitre plates gave similar 
results, and binding was abolished when the toxin 
was preincubated with ganglioside GMl. In order 
to establish the degree of contamination of the 
nuclear preparation with plasma membrane, it was 
OY 
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Fig.2. Binding of ‘2SI-labelled whole cholera toxin to a nuclear 
preparation from rabbit intestinal cells, corrected for non- 
specific binding. 
assayed for sucrase (a marker enzyme for the 
plasma membrane). The activity suggested that 
contamination could not have been more than 3% 
of the protein in the preparation; quite inadequate 
to account for the toxin binding. Efforts to iden- 
tify a specific binding protein by ‘Western blot’ 
analysis of the membrane preparation were not 
successful. 
4. DISCUSSION 
The experiments reported in this paper showed 
potential binding sites for cholera toxin associated 
with the nucleus. It seems likely that these sites are 
ganglioside GMl, the only receptor for the toxin 
that has been positively identified. This conclusion 
is supported by our observation that the binding is 
inhibited when toxin is preincubated with 
ganglioside and that the distribution in the cell of 
sites that bind anti-GM1 antibodies parallels that 
of toxin-binding sites. It is true that these an- 
tibodies did not interfere with the binding of toxin, 
but that could be easily explained if, as is probable, 
the affinity of the antibody for GM1 is lower than 
that of the toxin, or if the anti-GM1 does not bind 
to all the possible sites. 
It is still possible, however, that the binding site 
is not a ganglioside, but, for example, a glycopro- 
312 
Volume 242, number 2 FEBS LETTERS January 1989 
tein with a similar structure. Evidence from cell 
fractionation experiments, e.g. [14] has shown 
gangliosides in some intracellular membranes, but 
has usually been interpreted as showing no sign of 
gangliosides in the nucleus. On the other hand, 
binding of cholera toxin is probably the most sen- 
sitive available probe for ganglioside GMl. 
Our experiments do not imply that these 
nuclear-binding sites can be reached by the toxin 
when it is working in the intact cell or in vivo, nor 
do they in themselves suggest any physiological 
role for binding to the nucleus. 
Experiments on internalization of peroxidase- 
conjugated or 1Z51-labelled toxin into intact cells 
have shown the toxin to be associated with a 
number of intracellular organelles, e.g. the Golgi 
complex [ 151 and other intracellular vesicles [ 161. 
There has been no evidence for any particular 
binding to the nucleus. There is evidence, however, 
that gangliosides can be associated with cell growth 
and differentiation and so perhaps with gene ex- 
pression in the nucleus. For example, Spiegel and 
Fishman [17] have shown that the interaction of 
the B subunit of cholera toxin with ganglioside 
GM1 can act as a bimodal growth regulator of 
cells, acting synergistically with epidermal growth 
factor. 
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